$XRAY News

The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call

Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript

XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds

Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today

DENTSPLY SIRONA Q2 Earnings Call Highlights

1% Undervalued? DENTSPLY SIRONA (XRAY) As Earnings Test Its Recovery Story

Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings

DENTSPLY SIRONA Inc. Q2 2026 Earnings Call Summary

DENTSPLY SIRONA Inc. 2026 Q2 - Results - Earnings Call Presentation

Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript

Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations

Dentsply Sirona Reports Second Quarter 2026 Results

Dentsply Sirona Affirms FY2026 Adj EPS Guidance of $1.40-$1.50 vs $1.42 Est; Affirms FY2026 Sales Guidance of $3.500B-$3.600B vs $3.582B Est

Dentsply Sirona Q2 Adj. EPS $0.52 Beats $0.35 Estimate, Sales $898.000M Beat $889.810M Estimate

Can Dentsply Sirona (XRAY) Turn Its Business Around?

Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

3 Reasons to Sell XRAY and 1 Stock to Buy Instead

Dentsply Sirona to Host Second Quarter Conference Call on August 6th